000 | 04091naaaa2201081uu 4500 | ||
---|---|---|---|
001 | https://directory.doabooks.org/handle/20.500.12854/78746 | ||
005 | 20220714160655.0 | ||
020 | _abooks978-3-0365-2911-0 | ||
020 | _a9783036529110 | ||
020 | _a9783036529103 | ||
024 | 7 |
_a10.3390/books978-3-0365-2911-0 _cdoi |
|
041 | 0 | _aEnglish | |
042 | _adc | ||
072 | 7 |
_aM _2bicssc |
|
100 | 1 |
_aVejux, Anne _4edt _91570459 |
|
700 | 1 |
_aVejux, Anne _4oth _91570459 |
|
245 | 1 | 0 | _aCell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases : Mechanisms and Cytoprotective Molecules |
260 |
_aBasel _bMDPI - Multidisciplinary Digital Publishing Institute _c2022 |
||
300 | _a1 electronic resource (232 p.) | ||
506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
520 | _aNeurogenerative diseases encompass very different pathologies, which can be demyelinating or nondemyelinating, but which have common mechanisms such as cell death, oxidative stress and inflammation. A better understanding of these mechanisms allows the search for biomarkers and targets for new therapies. This special issue brings together different data on Alzheimer's disease, Parkinson's disease, and multiple sclerosis, detailing the mechanisms of cell death (necroptosis, ferroptosis), oxidative stress and inflammation but also the possibilities of neuroprotection via 5 research articles and 6 review articles. The different reviews allow us to take stock of cell death, oxidative stress and neuroinflammation in the context of neurodegenerative diseases but also in relation to other pathologies where these processes are involved. | ||
540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by/4.0/ _2cc _4https://creativecommons.org/licenses/by/4.0/ |
||
546 | _aEnglish | ||
650 | 7 |
_aMedicine _2bicssc |
|
653 | _aferroptosis | ||
653 | _acell death | ||
653 | _airon metabolism | ||
653 | _aneurodegenerative diseases | ||
653 | _aglutathione peroxidase 4 | ||
653 | _aGSH | ||
653 | _asystem xc− | ||
653 | _aAlzheimer's disease | ||
653 | _aParkinson's disease | ||
653 | _aHuntington's disease | ||
653 | _abreast cystic fluid | ||
653 | _aclozapine | ||
653 | _aendocytosis | ||
653 | _aglia | ||
653 | _aneurons | ||
653 | _aROS | ||
653 | _aneuroprotection | ||
653 | _aneuroinflammation | ||
653 | _acatechin | ||
653 | _aL-α-phosphatidylcholine | ||
653 | _aphosphatidylserine | ||
653 | _abrain ischemia | ||
653 | _astroke | ||
653 | _amicroglia | ||
653 | _aastrocytes | ||
653 | _aT lymphocytes | ||
653 | _amonocytes | ||
653 | _aplatelets | ||
653 | _amacrophages | ||
653 | _aleukocytes | ||
653 | _aneutrophils | ||
653 | _aMPTP | ||
653 | _anecroptosis | ||
653 | _aneurodegeneration | ||
653 | _asmall molecules | ||
653 | _ahyperglycemia | ||
653 | _ahyperinsulinemia | ||
653 | _aS100B protein | ||
653 | _aoxidative stress | ||
653 | _acentral nervous system (CNS) | ||
653 | _acancer | ||
653 | _atype 2 diabetes (T2DM) | ||
653 | _aneuropsychiatric disorders | ||
653 | _amood disorders | ||
653 | _acytokines | ||
653 | _ablood-brain barrier (BBB) | ||
653 | _aFLIM | ||
653 | _abrain injuries | ||
653 | _atraumatic | ||
653 | _adiffuse axonal injury | ||
653 | _ageniculate bodies | ||
653 | _amice | ||
653 | _anerve degeneration | ||
653 | _aneurofilament proteins | ||
653 | _aneuroglia | ||
653 | _aoptic tract | ||
653 | _asuperior colliculi | ||
653 | _asynaptophysin | ||
653 | _aTDP-43 proteinopathies | ||
653 | _aapoptosis | ||
653 | _anecrosis | ||
653 | _adocosahexaenoic acid | ||
653 | _aneurodegenerative disease | ||
653 | _ainflammation | ||
653 | _ananomedicine | ||
653 | _an/a | ||
856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/4838 _70 _zDOAB: download the publication |
856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/78746 _70 _zDOAB: description of the publication |
999 |
_c2978094 _d2978094 |